Investment Thesis
DGII demonstrates strong operational efficiency with 63.2% gross margins and exceptional 30% free cash flow conversion, supported by conservative leverage (0.21x D/E). However, revenue stagnation (0.0% YoY growth) and critically low returns on equity (3.5%) and assets (2.4%) indicate the company is a mature, cash-generative business failing to deploy its substantial $974M asset base efficiently.
Strengths
- Exceptional gross margins of 63.2% and strong operating margins of 13.2% demonstrate pricing power and operational excellence
- Outstanding free cash flow generation: $76M with 30% FCF margin indicates high-quality, sustainable cash earnings
- Conservative balance sheet with 0.21x debt-to-equity ratio and 5.3x interest coverage provides financial stability
Risks
- Zero revenue growth (0.0% YoY) signals business stagnation with no organic expansion trajectory
- Asset inefficiency is critical: only 3.5% ROE and 2.4% ROA despite $974M asset base indicates poor capital deployment
- Weak liquidity position with 0.77x quick ratio and minimal cash ($31.7M) against $143M long-term debt presents short-term vulnerability
Key Metrics to Watch
- Revenue growth in coming periods - sustainability of current trend is fundamental concern
- Return on equity and asset utilization improvements - whether capital base is being deployed more efficiently
- Free cash flow allocation - whether excess cash is reinforcing balance sheet or being distributed away
Financial Metrics
Revenue
253.2M
Net Income
23.0M
EPS (Diluted)
$0.60
Free Cash Flow
76.0M
Total Assets
974.2M
Cash
31.7M
Profitability Ratios
Gross Margin
63.2%
Operating Margin
13.2%
Net Margin
9.1%
ROE
3.5%
ROA
2.4%
FCF Margin
30.0%
Balance Sheet & Liquidity
Current Ratio
1.11x
Quick Ratio
0.77x
Debt/Equity
0.21x
Debt/Assets
31.6%
Interest Coverage
5.29x
Long-term Debt
143.0M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-08T09:55:27.493863 |
Data as of: 2026-03-31 |
Powered by Claude AI